Medical News

RSS

No link between lunar phases and incidence of psychological problems: Study

Contrary to popular belief, there is no connection between lunar phases and the incidence of psychological problems. This is the conclusion reached by a team of researchers directed by Professor Genevi-ve Belleville of Universit- Laval's School of Psychology after having examined the relationship between the moon's phases and the number of patients who show up at hospital emergency rooms experiencing psychological problems.

20 Nov 2012

3DISC to introduce QuantorMed+ Imaging Software at RSNA annual meeting

3DISC, a manufacturer of digital imaging solutions, will introduce its next-generation QuantorMed+ and QuantorVet+ Imaging Software at the 2012 Radiological Society of North America (RSNA) meeting in Chicago Nov. 25-30 (Booth #4406).

20 Nov 2012

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

Pfizer Inc. announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a statistically significant positive effect compared to placebo in the primary endpoint, time to loss of therapeutic response (LTR).

20 Nov 2012

3DISC to debut FireCR+M Readers at RSNA annual meeting

3DISC, a manufacturer of digital imaging solutions, will debut its next-generation FireCR+M Medical and FireCR+M Veterinary Readers at the 2012 Radiological Society of North America (RSNA) meeting in Chicago Nov. 25-30 (Booth #4406).

20 Nov 2012

TBI, age-related dementia and stroke fuel neurologic disability in India

The 'Global Perspectives' published in the Nov. 20, 2012 issue of Neurology-, the medical journal of the American Academy of Neurology, features "Neurologic Disability: A Hidden Epidemic for India".

20 Nov 2012

KLF4 genetic factor prevents blood vessels from blockages

Researchers at Case Western Reserve University School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.

20 Nov 2012

Smoking less a valid risk reduction strategy, says researcher

Countless studies demonstrate the virtues of complete smoking cessation, including a lowered risk of disease, increased life expectancy, and an improved quality of life. But health professionals acknowledge that quitting altogether can be a long and difficult road, and only a small percentage succeed.

20 Nov 2012

St. Jude Medical’s Portico transcatheter heart valve receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval for its 23 mm Portico Transcatheter Aortic Heart Valve and Transfemoral Delivery System.

20 Nov 2012

Illuminate PatientView to be introduced at Radiological Society of North America meeting

Illuminate PatientView, the newest application of Softek Illuminate's search engine and data aggregation technology, will be introduced at the Radiological Society of North America's annual meeting Nov. 25-30 at Chicago's McCormick Place and demonstrated by Softek associates in booth 9141.

20 Nov 2012

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

20 Nov 2012

Hebron introduces Florax DS Diarrhea Relief and Ready-to-Drink probiotic

Hebron U.S.A. Corp. is introducing their Florax DS product line featuring a Ready-to-Drink probiotic, for digestive and immune support and an all-natural probiotic diarrhea relief product that provides relief of occasional diarrhea, cramping, gas and bloating without the use of harsh chemicals.

20 Nov 2012

International Association of Eating Disorders Professionals symposium to be held in Nevada

The International Association of Eating Disorders Professionals (iaedp) announces its 2013 Symposium slated for March 21-24 at the Westin Lake Las Vegas Resort and Spa in Henderson, Nevada. The program is celebrating its 27th year with five keynote speakers as headliners addressing innovative approaches to eating disorder treatment as well as thirty-two workshop presenters and preconference training sessions.

20 Nov 2012

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Ventus Medical is pleased to announce the introduction of its proprietary Provent Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA).

20 Nov 2012

Public supports updating federal laws that require internet safety standards to protect kids

The Internet is full of information, but also full of real risks for children, like online predators or the pitfalls of losing privacy when kids share too much information. In a new University of Michigan poll, the majority of the public supports updating federal laws that require Internet safety standards to protect kids.

20 Nov 2012

New version of Optical Backscatter Reflectometer from Luna

Luna Innovations Incorporated today introduced a new version of its Optical Backscatter Reflectometer that's 200 times faster than competing solutions.

20 Nov 2012

Boston and Cincinnati Children's Hospital to learn more about how autism develops

A network of five leading medical centers, led by Cincinnati Children's Hospital Medical Center and Boston Children's Hospital, has received a five-year, $12.5 million National Institutes of Health (NIH) grant to learn more about how autism develops.

20 Nov 2012

CFFT announces major expansion of research collaboration with Pfizer

Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508.

20 Nov 2012

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.

20 Nov 2012

Patheon to launch $30 million transferable rights offering

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it will launch a U.S. $30 million transferable rights offering.

19 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

Medical News

No link between lunar phases and incidence of psychological problems: Study

3DISC to introduce QuantorMed+ Imaging Software at RSNA annual meeting

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

3DISC to debut FireCR+M Readers at RSNA annual meeting

TBI, age-related dementia and stroke fuel neurologic disability in India

KLF4 genetic factor prevents blood vessels from blockages

Smoking less a valid risk reduction strategy, says researcher

St. Jude Medical’s Portico transcatheter heart valve receives European CE Mark approval

Illuminate PatientView to be introduced at Radiological Society of North America meeting

Combination of perifosine and temsirolimus shows promise against malignant glioma

Hebron introduces Florax DS Diarrhea Relief and Ready-to-Drink probiotic

International Association of Eating Disorders Professionals symposium to be held in Nevada

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Public supports updating federal laws that require internet safety standards to protect kids

New version of Optical Backscatter Reflectometer from Luna

Boston and Cincinnati Children's Hospital to learn more about how autism develops

CFFT announces major expansion of research collaboration with Pfizer

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Patheon to launch $30 million transferable rights offering

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News